Serum- and glucocorticoid-regulated kinase 1 (SGK1) induction by the EWS/NOR1(NR4A3) fusion protein

被引:11
作者
Poulin, Hugo
Filion, Christine
Ladanyi, Marc
Labelle, Yves [1 ]
机构
[1] CHUQ, St Francois Assise Hosp, Human & Mol Genet Res Unit, Quebec City, PQ G1L 3L5, Canada
[2] Univ Laval, Fac Med, Ste Foy, PQ G1K 7P4, Canada
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
基金
加拿大自然科学与工程研究理事会;
关键词
EWS/NOR1; extraskeletal myxoid chondrosarcoma; SGK1; CFK2; cells;
D O I
10.1016/j.bbrc.2006.05.134
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The NR4A3 nuclear receptor (also known as NOR1) is involved in tumorigenesis by the t(9;22) chromosome translocation encoding the EWS/NOR1 fusion protein found in approximately 75% of all cases of extraskeletal myxoid chondrosarcomas (EMC). Several observations suggest that one role of EWS/NOR1 in tumorigenesis may be to deregulate the expression of specific target genes. We have shown previously that constitutive expression of EWS/NOR1 in CFK2 fetal rat chondrogenic cells induces their transformation as measured by growth beyond confluency and growth in soft agar. To identify genes regulated by the fusion protein in this model, we have generated a CFK2 cell line in which the expression of EWS/NOR1 is controlled by tetracycline. Using the differential display technique, we have identified the serum- and glucocorticoid-regulated kinase 1 (SGK1) mRNA as being up-regulated in the presence of EWS/ NOR1. Co-immunocytochemistry confirmed over-expression of the SGK1 protein in cells expressing EWS/NOR1. Significantly, immunohistochemistry of 10 EMC tumors positive for EWS/NOR1 showed that all of them over-express the SGK1 protein in contrast to nonneoplastic cells in the same biopsies and various other sarcoma types. These results strongly suggest that SGK1 may be a genuine in vivo target of EWS/NOR1 in EMC. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:306 / 313
页数:8
相关论文
共 41 条
[1]  
Adeyinka A, 2002, CLIN CANCER RES, V8, P3788
[2]  
Antonescu CR, 1998, CANCER, V83, P1504, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1504::AID-CNCR5>3.0.CO
[3]  
2-B
[4]  
Auwerx J, 1999, CELL, V97, P161
[5]  
BERNIER SM, 1993, J BONE MINER RES, V8, P475
[6]   Ubiquitin modification of serum and glucocorticoid-induced protein kinase-1 (SGK-1) [J].
Brickley, DR ;
Mikosz, CA ;
Hagan, CR ;
Conzen, SD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (45) :43064-43070
[7]  
Brody RI, 1997, AM J PATHOL, V150, P1049
[8]   Cell cycle and hormonal control of nuclear-cytoplasmic localization of the serum- and glucocorticoid-inducible protein kinase, Sgk, in mammary tumor cells - A novel convergence point of anti-proliferative and proliferative cell signaling pathways [J].
Buse, P ;
Tran, SH ;
Luther, E ;
Phu, PT ;
Aponte, GW ;
Firestone, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) :7253-7263
[9]   Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis [J].
Cheng, LEC ;
Chan, FKM ;
Cado, D ;
Winoto, A .
EMBO JOURNAL, 1997, 16 (08) :1865-1875
[10]   FSH-regulated gene expression profiles in ovarian tumours and normal ovaries [J].
Chu, S ;
Rushdi, S ;
Zumpe, ET ;
Mamers, P ;
Healy, DL ;
Jobling, T ;
Burger, HG ;
Fuller, PJ .
MOLECULAR HUMAN REPRODUCTION, 2002, 8 (05) :426-433